← Leaderboards
Stella T Chou
Children'S Hosp Of Philadelphia
$21,048,327
Attributed
$23,530,984
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2008–25$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,530,984 · 9
By mechanism
R01$10,295,665 · 4
U01$8,309,735 · 1
T32$2,007,726 · 1
R24$1,679,994 · 1
K08$669,600 · 1
R41$568,264 · 1
Top collaborators
- Mortimer Poncz4 shared
- Peter S Klein3 shared
- Zhe Zhang2 shared
- Jaclyn A Biegel1 shared
- Rob Thomas1 shared
- Mitchell J Weiss1 shared
- Peter S White1 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Gerd A Blobel$33,946,791
- Kaoru Takasaki$158,976
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesBloodTechnologyGeneticHematopoiesisProgenitorCellsProteinsInduced Pluripotent Stem CellErythroidGenotypeGata1 GeneProductionMegakaryocytesFetal LiverExhibitsFetalPhenotypeIn VitroVariantLeukemiaLifeChildCaring
Grant awards (33)
A precision therapy approach to red cell transfusion for sickle cell disease$795,499
R01 · FY2025 · HL · contact PI
Manufacturing Process Intensification for Pluripotent Stem Cell-Derived Rare Red Cell Production$568,264
R41 · FY2025 · HL
Pediatric Hematology Research Training Program$521,491
T32 · FY2025 · HL
A precision therapy approach to red cell transfusion for sickle cell disease$834,499
R01 · FY2024 · HL · contact PI
Pediatric Hematology Research Training Program$542,971
T32 · FY2024 · HL
Pediatric Hematology Research Training Program$448,251
T32 · FY2023 · HL
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$1,264,180
U01 · FY2022 · HL · contact PI
RH genotype matched red cell transfusions for patients with sickle cell disease$834,809
R01 · FY2022 · HL · contact PI
Pediatric Hematology Research Training Program$495,013
T32 · FY2022 · HL
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$1,264,180
U01 · FY2021 · HL · contact PI
RH genotype matched red cell transfusions for patients with sickle cell disease$834,809
R01 · FY2021 · HL · contact PI
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$1,264,180
U01 · FY2020 · HL · contact PI
RH genotype matched red cell transfusions for patients with sickle cell disease$834,809
R01 · FY2020 · HL · contact PI
Understanding the complexity of gene dosage imbalance in Down syndrome$3,352,210
R01 · FY2019 · HL · contact PI
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$1,264,180
U01 · FY2019 · HL · contact PI
RH genotype matched red cell transfusions for patients with sickle cell disease$853,809
R01 · FY2019 · HL · contact PI
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$1,264,180
U01 · FY2018 · HL · contact PI
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells$365,400
R01 · FY2018 · DK · contact PI
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$969,380
U01 · FY2017 · HL · contact PI
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells$365,400
R01 · FY2017 · DK · contact PI
Improving transfusion therapy for patients with sickle cell disease with pluripotent stem cell-derived red cells$1,019,455
U01 · FY2016 · HL · contact PI
Towards Precision Medicine in Childhood Acquired Aplastic Anemia$559,998
R24 · FY2016 · DK · contact PI
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells$365,400
R01 · FY2016 · DK · contact PI
Towards Precision Medicine in Childhood Acquired Aplastic Anemia$559,998
R24 · FY2015 · DK · contact PI
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells$471,218
R01 · FY2015 · DK · contact PI
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells$22,403
R01 · FY2015 · DK · contact PI
Towards Precision Medicine in Childhood Acquired Aplastic Anemia$559,998
R24 · FY2014 · DK · contact PI
Modeling genetic modifiers of hematopoiesis with induced pluripotent stem cells$365,400
R01 · FY2014 · DK · contact PI
Genetic modulators of erythro-megakaryocytic development$133,920
K08 · FY2012 · HL · contact PI
Genetic modulators of erythro-megakaryocytic development$133,920
K08 · FY2011 · HL · contact PI
Genetic modulators of erythro-megakaryocytic development$133,920
K08 · FY2010 · HL · contact PI
Genetic modulators of erythro-megakaryocytic development$133,920
K08 · FY2009 · HL · contact PI
Genetic modulators of erythro-megakaryocytic development$133,920
K08 · FY2008 · HL · contact PI